Hypha’s Q2 2019 Scientific Newsletter
July 3, 2019 4:16 pm Leave your thoughtsOur newsletter this quarter looks at the use of microbial biotransformation to synthesize glucuronide metabolites, with a particular emphasis on...
View Article
Our newsletter this quarter looks at the use of microbial biotransformation to synthesize glucuronide metabolites, with a particular emphasis on...
View Article
Hypha are excited to present a poster describing the application of PolyCYPs enzyme kits to create oxidised derivatives of drug...
View Article
We have just published an article on “Accessing Difficult-to-Synthesise Metabolites in Drug Development Programmes” in the April 2019 edition of...
View Article
22nd January, 2019 Hypha are pleased to announce the official launch of their PolyCYPs® kit, which provide a fast and...
View Article
Hypha are delighted to announce the appointment of Lisbet Kvaerno PhD as Head of Synthetic Chemistry at Hypha. Lisbet has...
View Article
We are pleased that a paper by Salter et al., 2018 has been published in Xenobiotica. The paper, entitled Microbial...
View Article
A 2018 Nature Reviews Drug Discovery paper by Bostrom et al on “Expanding the medicinal chemistry synthetic toolbox” features examples...
View Article
Zhou et al. presented a poster at the 2018 ISSX Conference in Montreal on “Elimination of [14C]-LY3023414 by Aldehyde Oxidase...
View Article
Hypha Discovery have issued a policy detailing our position on data protection in relation to the GDPR regulations that came...
View Article
Liam is attending the Drug Discovery Chemistry Lead Optimization for Drug Metabolism and Safety meeting on April 6th 2018 in...
View Article